1-aminoindan-1,5-dicarboxylic acid has been researched along with Parkinsonian Disorders in 1 studies
1-aminoindan-1,5-dicarboxylic acid: structure given in first source
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneda, K | 1 |
| Tachibana, Y | 1 |
| Imanishi, M | 1 |
| Kita, H | 1 |
| Shigemoto, R | 1 |
| Nambu, A | 1 |
| Takada, M | 1 |
1 other study available for 1-aminoindan-1,5-dicarboxylic acid and Parkinsonian Disorders
| Article | Year |
|---|---|
Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Behavior, Animal; Benzoate | 2005 |